NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether BrightSpring and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On or around January 25, 2024, BrightSpring conducted its initial public offering (“IPO”) of 53,333,334 shares of common stock priced at $13.00 per share. Then, on August 2, 2024, BrightSpring issued a press release announcing its financial results for the second quarter of 2024. Among other items, BrightSpring reported non-GAAP earnings per share of $0.10, missing consensus estimates by $0.03 per share.
On this news, BrightSpring’s stock price fell $1.07 per share, or 8.75%, to close at $11.16 per share on August 2, 2024.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
SOURCE Pomerantz LLP
